Open access · CC-BY
via OpenAlex
What is really known about the effects of nicotinamide riboside supplementation in humans
Mads V. Damgaard, Jonas T. Treebak
Science Advances · 2023 · ▲ 102 citations
Abstract
Nicotinamide riboside is a precursor to the important cofactor nicotinamide adenine dinucleotide and has elicited metabolic benefits in multiple preclinical studies. In 2016, the first clinical trial of nicotinamide riboside was conducted to test the safety and efficacy of human supplementation. Many trials have since been conducted aiming to delineate benefits to metabolic health and severe diseases in humans. This review endeavors to summarize and critically assess the 25 currently published research articles on human nicotinamide riboside supplementation to identify any poorly founded claims and assist the field in elucidating the actual future potential for nicotinamide riboside. Collectively, oral nicotinamide riboside supplementation has displayed few clinically relevant effects, and there is an unfortunate tendency in the literature to exaggerate the importance and robustness of reported effects. Even so, nicotinamide riboside may play a role in the reduction of inflammatory states and has shown some potential in the treatment of diverse severe diseases.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1126/sciadv.adi4862
- Canonical
- link ↗
- Fetched
- 2026-10-31 MST
Cite this
APA
Damgaard, M.V., & Treebak, J.T. (2023). What is really known about the effects of nicotinamide riboside supplementation in humans. <em>Science Advances</em>. https://doi.org/10.1126/sciadv.adi4862
Vancouver
Damgaard MV, Treebak JT. What is really known about the effects of nicotinamide riboside supplementation in humans. Science Advances. 2023. doi:10.1126/sciadv.adi4862.
BibTeX
@article{mads2023Whatis,
title = {What is really known about the effects of nicotinamide riboside supplementation in humans},
author = {Mads V. Damgaard and Jonas T. Treebak},
journal = {Science Advances},
year = {2023},
doi = {10.1126/sciadv.adi4862},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
University of Birmingham 2016
Open access · US-GOV
Nicotinamide Adenine Dinucleotide and Skeletal Muscle Metabolic Phenotype (NADMet)
Current Nutrition Reports 2023
Open access · OA
NAD+ Precursors Nicotinamide Mononucleotide (NMN) and Nicotinamide Riboside (NR): Potential Dietary Contribution to Health
The Journals of Gerontology Series A 2023
Preprint · OA
Dietary Supplementation With NAD+-Boosting Compounds in Humans: Current Knowledge and Future Directions
Institutional Repositories DataBase (IRDB)
Preprint · OA
Metabolism of orally administered Nicotinamide Riboside and Nicotinamide Mononucleotide in vivo
Scientific Reports 2023
Open access · CC-BY
Nicotinamide adenine dinucleotide metabolism and arterial stiffness after long-term nicotinamide mononucleotide supplementation: a randomized, double-blind, placebo-controlled trial
University of Colorado, Boulder 2015
Open access · US-GOV